NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE

Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs. Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta endocrinologica (Bucharest, Romania : 2005) Romania : 2005), 2018-04, Vol.14 (2), p.255-260
Hauptverfasser: Dirilenoglu, F, Kahraman Akkalp, A, Bag, H, Atasever Rezanko, T, Kucukodaci, Z
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs. Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favorable outcome. We have documented a rare case of an NE-ATC with its clinical, pathological, and molecular features. We also provided a thorough discussion of all the encapsulated ATCs reported in the literature. A 50-year-old woman with an unremarkable medical history, who presented with a thyroid nodule, and diagnosed as "follicular lesion of undetermined significance" by fine needle aspiration biopsy. The patient was lost to follow-up for six years and revisited upon her neck disturbances and underwent total thyroidectomy. Sections of the right lobe revealed a grossly encapsulated nodular lesion, measuring 75x55x55 mm. Histologically, the tumor consisted of both carcinomatous and sarcomatous components supported by immunohistochemical stains. Necrosis and atypical mitotic figures were evident. Capsular and/or vascular invasion was not identified. There were no BRAF codon 600, KRAS, NRAS mutations and RET/PTC rearrangement. During three-month follow-up, the patient was free of disease without adjuvant therapy. Encapsulated ATCs tend to follow a favorable clinical course and may deserve conservative treatment approaches.
ISSN:1841-0987
1843-066X
DOI:10.4183/aeb.2018.255